Add like
Add dislike
Add to saved papers

Case Report of a Successfully Treated Scopulariopsis Infection in a Bilateral Lung Transplant Recipient.

Scopulariopsis is a species of Aspergillus from the Microascaceae family. It has rarely been reported as a cause of human-borne infection. Here, we describe a 40-year-old female patient who had an invasive pulmonary Scopulariopsisinfection following bilateral lung transplant. During her routine follow-up posttransplant, new nodules were found on chest computed tomography imaging, bronchoalveolar lavage fluid cultures grew filamentous fungi, and lung biopsy was positive for Scopulariopsis. The patient had described a generalized weakness and fatigue for several weeks without cough or chest-related symptoms. After the patient received antifungal treatment, the nodules gradually disappeared, and she improved with good tolerance and without any adverse events. This was a rare case of proven invasive pulmonary Scopulariopsis infection in a lung transplant recipient that caused local disease and systemic infection, which we further analyzed by conducting a literature review. Ourreport can increase the current understanding pertaining to the treatment of a rare and lethal fungal opportunistic infection in immunocompromised humans.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app